[
  {
    "protocol_description": "TYBMW0RHdy6T",
    "file_description": "INqb3Snb4Ady",
    "data_type": "Assessment Results",
    "data_category": "PXTBdMh8foeZ",
    "data_format": "d5rrKZoygPSr",
    "md5sum": "499cf816ba7e5f600204a89ff7a70192",
    "file_size": 3,
    "file_name": "wjdpDoTWNeVJ",
    "type": "supplementary_file",
    "submitter_id": "supplementary_file_001",
    "studies": {
      "submitter_id": "study_001"
    }
  },
  {
    "protocol_description": "ERaEL6yFW1SO",
    "file_description": "R6LFr36RvGG1",
    "data_type": "Lab Test Results",
    "data_category": "euyxMJ0BGLO5",
    "data_format": "gbkAmtcpy0b8",
    "md5sum": "0a339d266be38fc11a6e08ae9cbada92",
    "file_size": 6,
    "file_name": "68JFUdGwRyJd",
    "type": "supplementary_file",
    "submitter_id": "supplementary_file_002",
    "studies": {
      "submitter_id": "study_002"
    }
  },
  {
    "protocol_description": "qrWHwkSMoIsv",
    "file_description": "oT8V8oVdw8Xj",
    "data_type": "Adverse Events",
    "data_category": "s58LcXVmwpx5",
    "data_format": "pvAxVYCKs53c",
    "md5sum": "fcf31ad3c4ee89525e9622ac3af4aa5a",
    "file_size": 5,
    "file_name": "rj8tWcu291KC",
    "type": "supplementary_file",
    "submitter_id": "supplementary_file_003",
    "studies": {
      "submitter_id": "study_003"
    }
  },
  {
    "protocol_description": "eLpwKVB1iAz9",
    "file_description": "EtsCjkg5iRH3",
    "data_type": "Substance Use",
    "data_category": "701tHkZhnxOO",
    "data_format": "apgv9xf3CvF6",
    "md5sum": "c144fe2f0fd5ff22dc8f73c49babf85d",
    "file_size": 5,
    "file_name": "g2dpRWdSxdgT",
    "type": "supplementary_file",
    "submitter_id": "supplementary_file_004",
    "studies": {
      "submitter_id": "study_004"
    }
  }
]
